Skip to main content
. 2016 Feb 5;6:20711. doi: 10.1038/srep20711

Table 3. Mixed model analysis by using time taken to reach minimum regional volume as dependent variable.

  ALL (n = 138)   Patients without LGE (n = 88)   Patients with QRS <120 ms (n = 117)  
Age 1.87 (0.61~3.13) 0.004 1.82 (0.53~3.11) 0.006 1.26 (0.32~2.21) 0.009
Sex (M vs. F) 8.07 (−21.41~37.58) 0.588 2.07 (−25.43~29.57) 0.881 −2.51 (−25.65~20.64) 0.830
LGE 6.02 (−67.82~79.87) 0.873 N/A N/A 5.55 (−59.14~70.25) 0.866
QRS >120 ms 18.70 (−17.84~55.25) 0.313 9.98 (−31.36~51.32) 0.632 N/A N/A
Diabetes mellitus −15.17 (−42.91~12.56) 0.281 6.51 (−20.51~33.54) 0.632 −4.03 (−25.26~17.21) 0.708
Hypertension 15.61 (−14.71~45.92) 0.310 −10.15 (−44.38~24.09) 0.556 −3.59 (−28.27~21.09) 0.774
CAD 11.32 (−16.81~39.45) 0.427 3.84 (−24.57~32.24) 0.788 −6.91 (−29.11~15.29) 0.538
LV mass index 0.07 (−0.61~0.47) 0.793 0.45 (−0.12~1.02) 0.117 0.03 (−0.47~0.41) 0.888
Group
 SHF vs. Control 4.00 (−46.83~54.82) 0.876 40.89 (−13.28~95.06) 0.137 14.02 (−24.32~52.35) 0.470
 HFpEF vs. Control 18.55 (−20.60~59.69) 0.369 18.95 (−11.16~49.06) 0.213 11.02 (−16.79~38.83) 0.433
 
 ECV 3.77 (2.72~4.81) <0.001 3.56 (1.75~5.37) <0.001 3.76 (2.64~4.89) <0.001
 LGE x ECV 8.45 (−219.62~236.53) 0.942 N/A   7.51 (−205.69~220.71) 0.945

Abbreviations: LGE, late gadolinium enhancement; CAD, coronary artery disease; SHF, systolic heart failure; HFpEF, heart failure with preserved ejection fraction; ECV, extracellular volume.